143 related articles for article (PubMed ID: 29433562)
1. The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy.
Zhang XG; Zhang YQ; Cheng QP; Cao Y; Sun JM; Lv XF
Eur J Med Res; 2018 Feb; 23(1):7. PubMed ID: 29433562
[TBL] [Abstract][Full Text] [Related]
2. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Fujita H; Sakamoto T; Komatsu K; Fujishima H; Morii T; Narita T; Takahashi T; Yamada Y
Hypertens Res; 2011 Dec; 34(12):1302-8. PubMed ID: 21814206
[TBL] [Abstract][Full Text] [Related]
3. The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.
Chen Y; Wu G; Xu M
Int Urol Nephrol; 2018 Jan; 50(1):97-103. PubMed ID: 29196928
[TBL] [Abstract][Full Text] [Related]
4. Yucca schidigera extract modulates the lead-induced oxidative damage, nephropathy and altered inflammatory response and glucose homeostasis in Japanese quails.
Farag MR; Alagawany M; Abd El-Hack ME; El-Sayed SAA; Ahmed SYA; Samak DH
Ecotoxicol Environ Saf; 2018 Jul; 156():311-321. PubMed ID: 29571109
[TBL] [Abstract][Full Text] [Related]
5. The oxidative stress status in diabetes mellitus and diabetic nephropathy.
Pan HZ; Zhang L; Guo MY; Sui H; Li H; Wu WH; Qu NQ; Liang MH; Chang D
Acta Diabetol; 2010 Dec; 47 Suppl 1():71-6. PubMed ID: 19475334
[TBL] [Abstract][Full Text] [Related]
6. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
[TBL] [Abstract][Full Text] [Related]
7. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between increase of oxidative stress and microalbuminuria in type-1 diabetic patients].
Artenie A; Artenie R; Ungureanu D; Covic A
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):777-81. PubMed ID: 16004216
[TBL] [Abstract][Full Text] [Related]
9. Losartan reduces insulin resistance by inhibiting oxidative stress and enhancing insulin signaling transduction.
Pan Y; Qiao QY; Pan LH; Zhou DC; Hu C; Gu HF; Fu SK; Liu XL; Jin HM
Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):170-7. PubMed ID: 25502581
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer.
Bolajoko EB; Mossanda KS; Adeniyi F; Akinosun O; Fasanmade A; Moropane M
S Afr Med J; 2008 Aug; 98(8):614-7. PubMed ID: 18928040
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy.
Serdar M; Sertoglu E; Uyanik M; Tapan S; Akin K; Bilgi C; Kurt I
Free Radic Res; 2012 Oct; 46(10):1291-5. PubMed ID: 22789030
[TBL] [Abstract][Full Text] [Related]
13. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
Food Chem Toxicol; 2014 Jan; 63():111-8. PubMed ID: 24211521
[TBL] [Abstract][Full Text] [Related]
14. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
15. [Advanced oxidation protein products in diabetic nephropathy patients and its relation with superoxide dismutase, glutathione peroxidase, neopterin].
Wu ZX; Xue YM; Li CZ; Guan MP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):704-7. PubMed ID: 16708815
[TBL] [Abstract][Full Text] [Related]
16. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats.
Kowluru RA; Abbas SN; Odenbach S
J Diabetes Complications; 2004; 18(5):282-8. PubMed ID: 15337502
[TBL] [Abstract][Full Text] [Related]
17. [Effect of short-term intensive treatment with insulin pump on beta cell function and the mechanism of oxidative stress in newly diagnosed type 2 diabetic patients].
Zhao QB; Wang HF; Sun CF; Ma AQ; Cui CC
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1878-9. PubMed ID: 18159009
[TBL] [Abstract][Full Text] [Related]
18. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
[TBL] [Abstract][Full Text] [Related]
19. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
[TBL] [Abstract][Full Text] [Related]
20. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
